Goa, India

Arijit Das

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • West Bengal, IN (2018)
  • West Bengal State, IN (2018 - 2019)
  • Kolkata, IN (2018 - 2020)
  • Goa, IN (2019 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Arijit Das: Innovator in Pharmaceutical Chemistry

Introduction

Arijit Das is a prominent inventor based in Goa, India, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the synthesis of important pharmaceutical compounds.

Latest Patents

Among his latest patents, Arijit has developed a process for the preparation of Rivaroxaban involving a novel intermediate. This invention relates to the key intermediate, 4-{4-[(SS)-(Aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]-phenyl}-morpholin-3-one perchlorate, which plays a crucial role in the synthesis of Rivaroxaban. The invention also includes the crystalline form of this novel intermediate, the process to prepare it, and the method of preparing Rivaroxaban using this intermediate. His work provides an improved and efficient process for the preparation of Rivaroxaban.

Career Highlights

Arijit Das is currently associated with Unichem Laboratories Limited, where he continues to innovate and contribute to the field of pharmaceutical research. His expertise in the synthesis of complex compounds has positioned him as a valuable asset in the industry.

Collaborations

He has collaborated with notable colleagues such as Dhananjay Govind Sathe and Yashwant S Surve, further enhancing the research and development efforts at Unichem Laboratories Limited.

Conclusion

Arijit Das exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborative efforts. His work not only advances the field but also contributes to the development of essential medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…